(Q38208466)

31 August 2017

Rationale for combining tamoxifen and interferon in the treatment of advanced breast cancer (English)

1 reference

31 August 2017

1 reference

F Porzsolt

1

1 reference

31 August 2017

A M Otto

2

1 reference

31 August 2017

B Trauschel

3

1 reference

31 August 2017

C Buck

4

1 reference

31 August 2017

A W Wawer

5

1 reference

31 August 2017

H Schönenberger

6

1 reference

31 August 2017

1 January 1989

1 reference

Journal of Cancer Research and Clinical Oncology

31 August 2017

1 reference

31 August 2017

115

1 reference

31 August 2017

5

1 reference

31 August 2017

465-469

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00393339

31 August 2017

0 references

cites work

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

1 reference

12 December 2020

Primary treatment of hairy cell leukemia: should IFN-therapy replace splenectomy?

1 reference

12 December 2020

An antiestrogenic action of interferons in human breast cancer cells

1 reference

12 December 2020

Different antitumor mechanisms of interferon-alpha in the treatment of hairy cell leukemia and renal cell cancer

1 reference

12 December 2020

1 reference

12 December 2020

Administration of fibroblast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors.

1 reference

12 December 2020

Synergistic combination of menogarol and melphalan and other two drug combinations

1 reference

12 December 2020

Antitumor actions of interferons. Direct, indirect, and synergy with other treatment modalities

1 reference

12 December 2020

Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.

1 reference

12 December 2020

Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells

1 reference

12 December 2020

Assay for estrogen and progesterone receptors of breast cancer cell lines in monolayer culture.

1 reference

12 December 2020

Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle

1 reference

12 December 2020

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

12 December 2020

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

1 reference

12 December 2020

Additive and synergistic effects of a novel antiestrogen, toremifene (Fc-1157a), and human interferons on estrogen responsive MCF-7 cells in vitro

1 reference

12 December 2020

Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen

1 reference

12 December 2020

A phase II study of human rDNA alpha-2 interferon in patients with low grade non-Hodgkin's lymphoma

1 reference

12 December 2020

Alpha interferon for induction of remission in hairy-cell leukemia

1 reference

12 December 2020

Interferon as a modifier of estrogen receptors

1 reference

12 December 2020

Multiple estrogen receptor assays in human breast cancer.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00393339

1 reference

31 August 2017

1 reference